6.
Vosler P, Brennan C, Chen J
. Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol Neurobiol. 2008; 38(1):78-100.
PMC: 2726710.
DOI: 10.1007/s12035-008-8036-x.
View
7.
Smith W, Gorospe M, Kusiak J
. Signaling mechanisms underlying Abeta toxicity: potential therapeutic targets for Alzheimer's disease. CNS Neurol Disord Drug Targets. 2006; 5(3):355-61.
DOI: 10.2174/187152706784111515.
View
8.
Ehrenberg A, Suemoto C, Resende E, Petersen C, Leite R, Rodriguez R
. Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease. J Alzheimers Dis. 2018; 66(1):115-126.
PMC: 6381997.
DOI: 10.3233/JAD-180688.
View
9.
Busche M, Wegmann S, Dujardin S, Commins C, Schiantarelli J, Klickstein N
. Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo. Nat Neurosci. 2018; 22(1):57-64.
PMC: 6560629.
DOI: 10.1038/s41593-018-0289-8.
View
10.
Francis B, Yang J, Hajderi E, Brown M, Michalski B, McLaurin J
. Reduced tissue levels of noradrenaline are associated with behavioral phenotypes of the TgCRND8 mouse model of Alzheimer's disease. Neuropsychopharmacology. 2012; 37(8):1934-44.
PMC: 3376325.
DOI: 10.1038/npp.2012.40.
View
11.
Chalermpalanupap T, Schroeder J, Rorabaugh J, Liles L, Lah J, Levey A
. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice. J Neurosci. 2017; 38(1):74-92.
PMC: 5761438.
DOI: 10.1523/JNEUROSCI.1483-17.2017.
View
12.
Aston-Jones G, Cohen J
. An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci. 2005; 28:403-50.
DOI: 10.1146/annurev.neuro.28.061604.135709.
View
13.
Watt G, Przybyla M, Zak V, van Eersel J, Ittner A, Ittner L
. Novel Behavioural Characteristics of Male Human P301S Mutant Tau Transgenic Mice - A Model for Tauopathy. Neuroscience. 2020; 431:166-175.
DOI: 10.1016/j.neuroscience.2020.01.047.
View
14.
Elrod R, Peskind E, Digiacomo L, Brodkin K, Veith R, Raskind M
. Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration. Am J Psychiatry. 1997; 154(1):25-30.
DOI: 10.1176/ajp.154.1.25.
View
15.
Rub U, Del Tredici K, Schultz C, Thal D, Braak E, Braak H
. The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer's disease-related cytoskeletal pathology. Acta Neuropathol. 2001; 101(6):555-64.
DOI: 10.1007/s004010000320.
View
16.
Robertson S, Plummer N, de Marchena J, Jensen P
. Developmental origins of central norepinephrine neuron diversity. Nat Neurosci. 2013; 16(8):1016-23.
PMC: 4319358.
DOI: 10.1038/nn.3458.
View
17.
Luster B, Cogan E, Schmidt K, Pati D, Pina M, Dange K
. Inhibitory transmission in the bed nucleus of the stria terminalis in male and female mice following morphine withdrawal. Addict Biol. 2019; 25(3):e12748.
PMC: 6785353.
DOI: 10.1111/adb.12748.
View
18.
Hoover B, Reed M, Su J, Penrod R, Kotilinek L, Grant M
. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron. 2010; 68(6):1067-81.
PMC: 3026458.
DOI: 10.1016/j.neuron.2010.11.030.
View
19.
Gong Y, Lippa C
. Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias. Am J Alzheimers Dis Other Demen. 2010; 25(7):547-55.
PMC: 2976708.
DOI: 10.1177/1533317510382893.
View
20.
Waterhouse B, Lin C, Burne R, Woodward D
. The distribution of neocortical projection neurons in the locus coeruleus. J Comp Neurol. 1983; 217(4):418-31.
DOI: 10.1002/cne.902170406.
View